Name: Lung Cancer, Part ii: Surgery and Adjuvant Therapies, an Issue of Thoracic Surgery Clinics, 1e (The Clinics: Surgery): Volume 23-3 (en Inglés)
Price: 94150.00 CLP
Availability: InStock
Author: Jean Deslauriers Md Frcps(C) Cm F. G. Pearson Md Farid M. Shamji Md Frcs C
ISBN: 9780323186179

portada Lung Cancer, Part ii: Surgery and Adjuvant Therapies, an Issue of Thoracic Surgery Clinics, 1e (The Clinics: Surgery): Volume 23-3 (en Inglés)

Lung Cancer, Part ii: Surgery and Adjuvant Therapies, an Issue of Thoracic Surgery Clinics, 1e (The Clinics: Surgery): Volume 23-3 (en Inglés)

Formato

Libro Físico

Editorial

Elsevier 2013-09-16,

Autor

Jean Deslauriers Md Frcps(C) Cm F. G. Pearson Md Farid M. Shamji Md Frcs C

Idioma

Inglés

Encuadernación

Tapa Dura

ISBN13

9780323186179

Lung Cancer, Part ii: Surgery and Adjuvant Therapies, an Issue of Thoracic Surgery Clinics, 1e (The Clinics: Surgery): Volume 23-3 (en Inglés)

Jean Deslauriers Md Frcps(C) Cm F. G. Pearson Md Farid M. Shamji Md Frcs C (Autor) · Elsevier 2013-09-16, · Tapa Dura

Libro Nuevo Importado

Envío: 18 a 22 días háb.

$ 171.190$ 94.150

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 94.150

Llega entre el 21 Ago y el 27 Ago a Santiago, Región Metropolitana. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Lung Cancer, Part ii: Surgery and Adjuvant Therapies, an Issue of Thoracic Surgery Clinics, 1e (The Clinics: Surgery): Volume 23-3 (en Inglés)"

This issue of Thoracic Surgery Clinics, Guest Edited by Drs. Jean Deslauriers, F.G. Pearson, and Farid Shamji, is devoted to surgery and chemotherapy for lung cancer. This issue was written as a tribute to Dr. Robert J. Ginsberg, and will include articles on: Contemporary results of surgical resection of NSCLC after induction therapy; Prediction of operative morbidity and mortality before operation; Limited resection for small diameter tumors; Management of tumors involving the chest wall, including Pancoast tumors and tumors invading the spine; Role of surgery in patients with clinical N2 disease; Reconstruction of the bronchus and pulmonary artery; Current status of systematic lymph node dissection versus lymph node sampling; Intraoperative nodal staging: Role of sentinel node technology; Stereotactic body radiation therapy (SBRT) in early stage tumors; Palliative resection; Adjuvant chemotherapy after pulmonary resection for lung cancer; Targeted therapy and new anti-cancer drugs in advanced disease; Biologic approaches to drug selection and targeted therapies; Cost effective methods for follow-up after lung cancer surgery; Quality of life after pulmonary resection; and Principles of palliative care.